Cargando…

The Role of Myocardial Mitochondrial Quality Control in Heart Failure

At present, the treatment of heart failure has entered the plateau phase, and it is necessary to thoroughly study the pathogenesis of heart failure and find out the corresponding treatment methods. Myocardial mitochondria is the main site of cardiac energy metabolism, whose dysfunction is an importa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Zhiling, Wei, Yi, Song, Qingqiao, Du, Bai, Wang, Huan, Chu, Yuguang, Hu, Yuanhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910121/ https://www.ncbi.nlm.nih.gov/pubmed/31866862 http://dx.doi.org/10.3389/fphar.2019.01404

Ejemplares similares

Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications
por: Chai, Ruoning, et al.
Publicado: (2022)

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK
por: Shu, Hongyang, et al.
Publicado: (2021)

The Role of Autophagy in Acute Myocardial Infarction
por: Wu, Du, et al.
Publicado: (2019)

Dapagliflozin Attenuates Myocardial Fibrosis by Inhibiting the TGF-β1/Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure
por: Chen, Xuefeng, et al.
Publicado: (2022)

Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction
por: Yu, Siyi, et al.
Publicado: (2023)

Proteomic Analysis Reveals the Protective Effects of Yiqi Fumai Lyophilized Injection on Chronic Heart Failure by Improving Myocardial Energy Metabolism
por: Han, Xiaoying, et al.
Publicado: (2021)

AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics
por: Du, Jingxia, et al.
Publicado: (2022)

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Role of m6A Methylation in the Occurrence and Development of Heart Failure
por: Fan, Shaowei, et al.
Publicado: (2022)

Honokiol Ameliorates Post-Myocardial Infarction Heart Failure Through Ucp3-Mediated Reactive Oxygen Species Inhibition
por: Liu, Jianyu, et al.
Publicado: (2022)

Circulating Circular RNAs: Novel Biomarkers for Heart Failure
por: Sun, Chuan, et al.
Publicado: (2020)

Corrigendum: Honokiol ameliorates post-myocardial infarction heart failure through Ucp3-mediated reactive oxygen species inhibition
por: Liu, Jianyu, et al.
Publicado: (2022)

Efficacy and safety of Shenfu injection for the treatment of post-acute myocardial infarction heart failure: A systematic review and meta-analysis
por: Wu, Yanhua, et al.
Publicado: (2022)

Identification of key pharmacodynamic markers of American ginseng against heart failure based on metabolomics and zebrafish model
por: Dong, Rong, et al.
Publicado: (2022)

Construction of a Non-Mutually Exclusive Decision Tree for Medication Recommendation of Chronic Heart Failure
por: Bai, Yongyi, et al.
Publicado: (2022)

Screening of anti-heart failure active compounds from fangjihuangqi decoction in verapamil-induced zebrafish model by anti-heart failure index approach
por: Li, Jun, et al.
Publicado: (2022)

Salsolinol Attenuates Doxorubicin-Induced Chronic Heart Failure in Rats and Improves Mitochondrial Function in H9c2 Cardiomyocytes
por: Wen, Jianxia, et al.
Publicado: (2019)

The multifaceted roles of natural products in mitochondrial dysfunction
por: Chen, Qianrun, et al.
Publicado: (2023)

Cell-Based Therapies for Heart Failure
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2021)

Velvet Antler Ameliorates Cardiac Function by Restoring Sarcoplasmic Reticulum Ca(2+)-ATPase Activity in Rats With Heart Failure After Myocardial Infarction
por: Shi, Haoyue, et al.
Publicado: (2021)

Yang-xin-xue keli exerts therapeutic effects via regulating mitochondrial homeostasis and function in doxorubicin-induced rat heart failure
por: Long, Kunlan, et al.
Publicado: (2022)

Role of resveratrol in inhibiting pathological cardiac remodeling
por: Fan, Shaowei, et al.
Publicado: (2022)

Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients
por: Wang, Dong-Dong, et al.
Publicado: (2022)

Cyclic GMP and PKG Signaling in Heart Failure
por: Numata, Genri, et al.
Publicado: (2022)

Integrative analyses of biomarkers and pathways for heart failure
por: Fan, Shaowei, et al.
Publicado: (2022)

The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis
por: Yang, Yi, et al.
Publicado: (2023)

Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
por: Zhang, Qian, et al.
Publicado: (2020)

Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review
por: Wu, Meiyu, et al.
Publicado: (2022)

Factors Associated With Hospital Readmission of Heart Failure Patients
por: Al-Tamimi, Maitha Abdul-Aziz, et al.
Publicado: (2021)

Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure
por: Wang, Anzhu, et al.
Publicado: (2022)

Cost effectiveness analyses of pharmacological treatments in heart failure
por: Lim, Audrey Huili, et al.
Publicado: (2022)

Cost-utility analysis of empagliflozin in heart failure patients with reduced and preserved ejection fraction in China
por: Tang, Yi, et al.
Publicado: (2022)

GRKs and β-Arrestins: “Gatekeepers” of Mitochondrial Function in the Failing Heart
por: Sorriento, Daniela, et al.
Publicado: (2019)

Irisin Attenuates Myocardial Ischemia/Reperfusion Injury and Improves Mitochondrial Function Through AMPK Pathway in Diabetic Mice
por: Xin, Chao, et al.
Publicado: (2020)

Role of Higenamine in Heart Diseases: A Mini-Review
por: Wen, Jianxia, et al.
Publicado: (2022)

Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
por: Shi, Shuqing, et al.
Publicado: (2022)

The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
por: Gao, Jinquan, et al.
Publicado: (2023)

Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool
por: Bao, Xiao-yi, et al.
Publicado: (2018)

Immunomodulatory Treatment Strategies Targeting B Cells for Heart Failure
por: Zhang, Xinxin, et al.
Publicado: (2022)

Phosphoproteomic and proteomic profiling in post-infarction chronic heart failure
por: Wang, Jiayue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o8e7fitegp1115vtqef0416e3n